Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Myeloproliferative Neoplasms Clinical Trials
Myeloproliferative Neoplasms clinical trials are recruiting across 78 cities. Here are the cities with the most active studies:
Myeloproliferative Neoplasms Trial Phases
38 research organizations are sponsoring myeloproliferative neoplasms trials.
About Myeloproliferative Neoplasms
Myeloproliferative neoplasms (MPNs) are blood cancers in which the bone marrow overproduces red blood cells, platelets, or white blood cells. Types include polycythemia vera, essential thrombocythemia, and myelofibrosis. Treatment depends on the specific type and risk factors.
Clinical trials are advancing new treatments for myeloproliferative neoplasms. Currently, 48 studies are recruiting a combined 11,190 participants across the United States. Research is being conducted by 38 organizations including MPN Research Foundation, FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS, Center for International Blood and Marrow Transplant Research and 35 others.
2026 Myeloproliferative Neoplasms Research Landscape
As of July 2026, the myeloproliferative neoplasms clinical trial landscape includes 48 actively recruiting studies across 78 cities in the United States. These studies are collectively seeking 11,190 participants, with an average enrollment target of 233 per study.
The research spans multiple phases of development: 28 studies are in PHASE1, 21 studies are in PHASE2, 5 studies are in PHASE3, 1 study is in EARLY_PHASE1. The presence of Phase 3 trials indicates that some myeloproliferative neoplasms treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 38 different organizations, including MPN Research Foundation, FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS, Center for International Blood and Marrow Transplant Research, Kartos Therapeutics, Inc., Novartis Pharmaceuticals, and 33 others. The large number of sponsors reflects significant research interest and investment in myeloproliferative neoplasms treatment advancement.
Geographically, myeloproliferative neoplasms trials are most concentrated in New York, New York (16 trials); Tampa, Florida (8 trials); Ann Arbor, Michigan (7 trials); Boston, Massachusetts (7 trials); Houston, Texas (7 trials) and 7 other cities.
Featured Myeloproliferative Neoplasms Studies
Highlighted recruiting studies for myeloproliferative neoplasms, selected by enrollment size and research scope.
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
The MPN PROGRESSion Registry is a multi-year, observational research study designed to improve understanding of myeloproliferative neoplasms (MPNs)-a group of rare, chronic blood cancers that include polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (MF), pre-fibrotic primary myelofibrosis (pre-PMF), secondary myelofibrosis, myeloproliferative neoplasm-unclassifiable (M...
A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes
International multicenter retrospective observational study consisting of two parts: a nested case-control study (part A) and a comparative retrospective cohort study (part B).
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
This observational study will compare outcomes of a prospectively-enrolled cohort of Hematopoietic Stem Cell Transplant (HCT) recipients with outcomes of a cohort of age-matched historical non-HCT controls. Patients undergoing alloHCT will receive HCT in a US transplant center and be reported to the Center for International Blood and Marrow Transplant Research (CIBMTR) using well-established CIBMT...
Frequently Asked Questions About Myeloproliferative Neoplasms Clinical Trials
Are there myeloproliferative neoplasms clinical trials near me?
Yes, there are 48 myeloproliferative neoplasms clinical trials currently recruiting across 78+ cities in the United States, including New York, New York; Tampa, Florida; Ann Arbor, Michigan. Browse the studies above to find one at a location convenient for you.
How do I join a myeloproliferative neoplasms clinical trial?
To join a myeloproliferative neoplasms clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are myeloproliferative neoplasms clinical trials free?
Yes, participation in myeloproliferative neoplasms clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of myeloproliferative neoplasms treatments are being studied?
Current myeloproliferative neoplasms clinical trials are testing a range of approaches across PHASE1 (28 studies), PHASE2 (21 studies), PHASE3 (5 studies), EARLY_PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 38 research organizations.
Is it safe to participate in myeloproliferative neoplasms clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov